Apotex, Inc
Products
Full Paper
Price: £95.00
Description: The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Published Date: 05/06/2011
Category: Drug Delivery & Devices
Research Report Decription
Apotex,
Inc. - Strategy and SWOT Report, is a source of comprehensive company data and
information. The report covers the company’s structure, operation, SWOT
analysis, product and service offerings and corporate actions, providing a 360˚
view of the company.
Features:
- Detailed information on Apotex, Inc.
required for business and competitor intelligence needs
-
A study of the major internal and
external factors affecting Apotex, Inc. in the form of a SWOT analysis
-
An indepth view of the business model of
Apotex, Inc. including a breakdown and examination of key business segments
- Intelligence on Apotex, Inc.’s mergers
and acquisitions (M&A), strategic partnerships and alliances, capital
raising, private equity transactions, and financial and legal advisors
- News about Apotex, Inc., such as
business expansion, restructuring, and contract wins
-
Large number of easy-to-grasp charts and
graphs that present important data and key trends
Key Questions Answered:
- Gain understanding of the Apotex, Inc.
and the factors that influence its strategies
-
Track strategic initiatives of the company
and latest corporate news and actions
-
Assess Apotex, Inc. as a prospective
partners, vendor or supplier
-
Support sales activities by
understanding your customers' businesses better
-
Stay up to date on Apotex, Inc.’s
business structure, strategy and prospect
Companies Mentioned:
Apotex, Inc.
Paper Highlights:
Apotex
is the largest privately-owned generics company in Canada. It is engaged in the
research, development, manufacture and distribution of generic prescription
drugs and also of fine chemicals, non-prescription and private label medicines,
and disposable plastics for medical use. The company exports its products to
more than 115 countries. The company is headquartered in Ontario, Canada and
employs more than 6,800 people.As Apotex is a private company, it is not
obliged to release its financial results for public.